Biotech and Money London 2018 | Biotech and Money | 5 February 2018 | etc.venues St Paul's, 200 Aldersgate, St. Pauls, London EC1A 4HD UK

The 4th annual Biotech and Money / Medtech and Money World Congress is a high-calibre, senior Executive, two-day conference and partnering event providing the education, strategies, solutions and contacts that life science companies need to enable more effective investment, business planning and partnering within their businesses.

With our relentless focus on quality peer-2-peer discussion, high-level networking and partnering, unique formats and a vetted, high-calibre audience, we bring together the people that matter to the future of healthcare and life science funding, finance, investment and deal making.

The 2017 conference officially attracted the largest gathering of active Life Science investors in Europe, making it the go to event for Executives looking to engage in investment and partnering discussions. It's the must attend 2018 event for corporates, investors and pharma.

2018 Speakers:

Chandra P Leo
Investment Advisor, Hbm Partners

Hubert Birner
Managing Partner, Tvm Capital Life Science

Sander Slootweg
Managing Director, Forbion Capital Partners

Kate Bingham
Managing Partner, Sv Life Sciences

Iain Dukes
Venture Partner, Orbimed

Paul Saunders
Head of Innovation Investments, Ireland's Strategic Investment Fund

Alain Huriez
Chairman and Managing Partner, Advent France Biotechnology

Iain Thomas
Head of Life Sciences, Cambridge Enterprise

Paul Ashley
Head of Technology Transfer, Oxford University Innovation

Tony Hickson
Managing Director, Tech Transfer, Imperial Innovations

Pascale Auge
Ceo, Inserm Transfert

Viktor Drvota
Ceo, Karolinska Development

Giovanni Mariggi
Principal, Medicxi

Deborah Harland
Partner, Sr-one

Dirk Kersten
Managing Director, Inkef Capital

Jonathan Goldstein
Director, Corporate Research and Ventures, Boston Scientific Ventures

Nissim Darvish
Senior Managing Director, Orbimed

Piyush Unalkat
Head of Technology Transfer, Eif

Gerry Maguire
General Partner, Atlantic Bridge

Soren Moller
Managing Partner, Novo Seeds

Frank Hensel
Senior Investment Manager, High-tech Grunderfonds

Edward Van Wezel
Managing Partner, Biogeneration Ventures

Edoardo Negroni
Managing Partner, Aurora-tt

John Zai
Ceo, Cocoon Networks

Claudio Rumazza
Partner, Innogest

Christoph Ruedig
Partner, Albion Ventures

Alexia Perouse
Ceo, Ibionext Growth Fund

Martin Pfister
Senior Investment Manager, High-tech Grunderfonds

Johnston Erwin,
Vp, Corporate Business Development

Jasper Bos
Vice President, Head of the Healthcare Fund

Onno Van De Stolpe
Ceo, Galapagos

Darrin Disley
Ceo, Horizon Discovery Group

Edwin Moses
Ceo, Ablynx

Joachim Rautter
Managing Director, Peppermint

Daniel O'mahony
Partner, Seroba Life Sciences

Thom Rasche
Partner, Earlybird Venture Capital

Janke Dittmer
Partner, Gilde Healthcare

Tim Luker
Senior Director, Emerging Technology and Innovation, Business Development, Eli Lilly & Co.

Timothy Herpin
Vp and Head of Transactions and Bd, Astrazeneca

Hans Loibner
Ceo, Apeiron Biologics

James Shaw
Co-founder, Jag Shaw Baker

Jennifer Laird
Senior Director, Neuroscience & Cns, Eli Lilly & Co.

Martin Frost
Ceo, Cambridge Medical Robotics

Tommi Lehtonen
Ceo, Blueprint Genetics

Billy Boyle
Ceo, Owlstone Therapeutics

Sarah Howell
Ceo, Arecor

Neil Clark
Ceo, Destiny Pharma

Richard Davies
Ceo, Bone Support

Jean-philippe Combal
Ceo, Vivet Therapeutics

Rob De Ree
Chairman, Mellon Medical

Steve Atkinson
Ceo, Atlantic Therapeutics, Atlantic Therapeutics

Marc Lemonnier
Ceo, Antabio

Pierre Chauvineau
Vp, Boston Scientific

Adam Hill
Cmo, Mclaren Applied Technologies

Isobel Finnie
Partner, Haseltine Lake

Joe Anderson
Ceo, Arix Bioscience

Pawel Przewiezlikowski
Ceo, Selvita

Isabel Van De Keere
Ceo, Immersive Rehab

Henri Francois Boedt
Senior Loan Officer, European Investment Bank

Christoph Kausch
Founding Partner and Ceo, Mtip Medtech Innovation Partners

David Berry
General Partner, Flagship Pioneering

Martin Murphy
Ceo, Syncona Partners

Elisa Petris
Partner, Syncona Partners

Joe Anderson
Ceo, Arix Biosciences

Philippe Lopes-fernandes
Svp, Head of Global Business Development & Alliance Management, Emd Serono

Naveed Siddiqi
Partner, Edmond De Rothschild Investment Partners

David Hipkiss
Ceo, Enesi Pharma

Andrew Shailer-smith
Ceo, Astraveus

Sourabh Pagaria
Senior Vice President and General Manager, Enterprise Services & Solutions, Siemens Healthineers

Beverley Carr
Business Development, Immunoinflammation Therapy Area, Gsk

Xavier Bertrand
Global Gm Symetis & Vp International Sh Valves, Boston Scientific

Niels Riedemann
Ceo, Inflarx

Adam Kostyál
Svp and Head of European Listings, Nasdaq

Asaf Homossany
Managing Director, Emea, Nasdaq

Tim Haines
Managing Partner, Abingworth

Elaine Warburton
Ceo, Quantumdx

Erica Whittaker
Head of Ucb Ventures, Ucb Pharma

Niall Martin
Ceo, Artios Pharma

Simon Hubbert
Ceo, Lig Technologies

Tim Wilson
Ceo, Igem Therapeutics

Paul Ko Ferrigno
Ceo, Metalinear

Shaun Grady
Vp Global Business Development, Astrazeneca

Timm Jessen
Ceo, Topas Therapeutics

Jean Christophe Renondin
Senior Investment Manager Healthcare, Oman Investment Fund

Rainer Lichtenberger
Ceo, Atriva Therapeutics

Assaf Barnea
Ceo, Sanara Ventures

Celine-lea Halioua-haubold
Ceo, Oisin Biotechnologies

Florence Sejourne
Ceo, Da Volterra

Patrick Van Beneden
Partner, Gimv

James Greene
Ceo, Medlumics

Clive Cookson
Science Editor,financial Times

Vanessa Malier
Managing Partner, Kurma Partners

Tushar Singhvi
Vp Corporate Development and Investments, Crescent Enterprises

Theresa Deisher
Ceo, Avm Biotechnology

Miguel Costa
Ceo, Aglaris Cell

Rodger Novak
Ceo, Crispr Therapeutics

Christian Schetter
Ceo, Rigontec

Pavithra Sundaresan
Senior Director New Ventures and Transaction Lead, J & J Innovation

Phil L'huillier
Head European Innovation Hub, Msd

Carlos De Sousa
Ceo, Immunicium

Fred Jacobs
Ceo, Tyg - Oncology

Randolph Hubbell
Ceo, Carmell Therapeutics

Thomas Lienard
Ceo, Bone Therapeutics

Martin Ostermaier
Ceo, Interax

Raúl Insa
Ceo, Som Biotech

Tauhid Ali
Vp Head of Tak-celerator, Takeda

Christopher Cleary
Vp Corporate Development, Medtronic

Pekka Simula
Ceo, Herantis Pharma

Michael Stein
Ceo, Oxstem

Angus Grant
Svp Business Development, Celgene

Gita Dittmar
Head of Corporate Development, Ethris

Tara Raveendran
Head of Life Sciences Research, Shore Capital

2018 Partners:

PLATINUM:
• Cocoon Networks
• Ey
• Eli Lilly & Co.
• Medtronic
• Nasdaq

GOLD:
• Allen & Overy
• Brown Rudnick
• Carnegie
• Cooley
• Covington
• Jag Shaw Baker
• Leerink
• N+1 Singer
• Seroba
• Seroba
• White & Case

SILVER:
• Gje
• Capital Cell
• Haseltine Lake

ASSOCIATES:
• Alacrita
• Arthur J Gallagher
• Barclays
• Boult Wade Tennant
• Cancer Research Uk
• Clinigen
• Cms
• Eqs Group
• Invest Newcastle
• Marks & Clerks

STRATEGIC:
• Citigate Dewe Rogerson
• Consilium
• Instinctif
• Mc Services
• Optimum Communications
• Sciad

MEDIA:
• Biopharm Insight
• Canbiotech
• Freemind
• Kash Biotech
• Mednous
• Pharma Ventures
• Swiss Biotech